All
Cancer Treatment-Induced Dry Mouth is ‘Much More Consequential Than It Sounds’
October 9th 2020Cancer-treatment induced dry mouth can lead to several severe health issues. Here, Dr. Randy Kimple discusses how the side effect can lead to dental health issues, as well as other health consequences including pneumonia.
‘We Need to Do Better’ for Patients with Cancer Suffering from Treatment-Related Dry Mouth
October 8th 2020Outside of drinking plenty of water or avoiding foods that can induce dry mouth, Dr. Randy Kimple notes that there are very few effective treatments for patients who experience cancer treatment-related dry mouth.
Ibrance Plus Faslodex in Hormone-Driven Advanced Breast Cancer Delays Disease Progression
October 6th 2020In a clinical trial, adding the CDK4/6 inhibitor Ibrance (palbociclib) to the hormonal treatment Faslodex (fulvestrant) delayed disease progression in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.
How COVID-19 Robs Patients with Cancer of Their Precious Time
October 6th 2020Time is a valuable commodity, especially for patients with cancer who may find themselves with limited time or limited free time to enjoy the things they loved prior to their cancer. But the COVID-19 pandemic is robbing patients of that precious time.
Cabometyx-Tecentriq Combo Shows Promise in Advanced Kidney Cancer
October 5th 2020“The combination of cabozantinib (Cabometyx) and atezolizumab (Tecentriq) demonstrated encouraging clinical activity in previously untreated patients with advanced ccRCC,” Dr. Sumanta Kumar Pal, co-director of the Kidney Cancer Program at City of Hope in California, said during a presentation of the clear cell renal cell carcinoma cohort.
FDA Approves Opdivo-Yervoy Combo for Unresectable Malignant Pleural Mesothelioma
October 2nd 2020The Food and Drug Administration’s approval of Opdivo in combination with Yervoy for patients with unresectable malignant pleural mesothelioma marks the first new systemic therapy approved in more than 15 years in this setting.
Where is The Balance Between Prostate Cancer Screening and Overtreatment?
October 2nd 2020After a recommendation against routine prostate cancer screening, rates of early disease declined while the incidence of advanced disease rose. The trend highlights the difficult balance between screening and potential overtreatment.